{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:37:54Z","timestamp":1780414674955,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy: Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omton.2024.200840","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T16:21:57Z","timestamp":1719246117000},"page":"200840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential of sonobiopsy as a novel diagnosis tool for brain cancer"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9079-8826","authenticated-orcid":false,"given":"Li","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2024.200840_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7150\/thno.65597","article-title":"Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA","volume":"12","author":"Pacia","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.omton.2024.200840_bib2","article-title":"Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation","volume":"15","author":"Zhu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200840_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-bioeng-062117-121238","article-title":"Therapeutic Agent Delivery Across the Blood-Brain Barrier Using Focused Ultrasound","volume":"23","author":"McMahon","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.omton.2024.200840_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/neuonc\/noab057","article-title":"MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors","volume":"23","author":"Meng","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omton.2024.200840_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omton.2024.200840_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.omton.2024.200840_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature06913","article-title":"The cancer biomarker problem","volume":"452","author":"Sawyers","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omton.2024.200840_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060945","article-title":"Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer","volume":"17","author":"Tsai","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bcp.2019.03.011","article-title":"An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets","volume":"163","author":"Wu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omton.2024.200840_bib12","article-title":"DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer","volume":"1877","author":"M\u00fcller","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Canc."},{"key":"10.1016\/j.omton.2024.200840_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2011.12.030","article-title":"Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation","volume":"342","author":"Copped\u00e8","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2024.200840_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155311","article-title":"Biomarkers in Colorectal Cancer: Current Research and Future Prospects","volume":"21","author":"Ogunwobi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020852","article-title":"Novel Diagnostic Biomarkers in Colorectal Cancer","volume":"23","author":"Zygulska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032185","article-title":"Biomarkers of Aggressive Prostate Cancer at Diagnosis","volume":"24","author":"Boehm","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107932","article-title":"Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics","volume":"228","author":"Adamaki","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omton.2024.200840_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10408363.2022.2033161","article-title":"Prostate cancer biomarkers: a practical review based on different clinical scenarios","volume":"59","author":"Falagario","year":"2022","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.omton.2024.200840_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2014.10.020","article-title":"Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer","volume":"81","author":"Rachagani","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omton.2024.200840_bib20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12885-019-6284-y","article-title":"MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators","volume":"19","author":"Daoud","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2024.200840_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2020.04.002","article-title":"Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers","volume":"223","author":"Ozawa","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.omton.2024.200840_bib22","article-title":"Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond","volume":"19","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pharmrev.122.000788","article-title":"Emergence of Extracellular Vesicles as \"Liquid Biopsy\" for Neurological Disorders: Boom or Bust","volume":"76","author":"Kumar","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.omton.2024.200840_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.semcancer.2022.11.004","article-title":"Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma","volume":"87","author":"Rackles","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omton.2024.200840_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11912-018-0706-x","article-title":"The Utility of Liquid Biopsy in Central Nervous System Malignancies","volume":"20","author":"Nevel","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.omton.2024.200840_bib26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1586\/14737159.2015.1087315","article-title":"Emerging circulating biomarkers in glioblastoma: promises and challenges","volume":"15","author":"Touat","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.omton.2024.200840_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137039","article-title":"Molecular and Circulating Biomarkers of Brain Tumors","volume":"22","author":"Jelski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3892\/ijo.2015.3026","article-title":"Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)","volume":"47","author":"Cabrini","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib29","first-page":"6962","article-title":"Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme","volume":"63","author":"Shinojima","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib30","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","article-title":"Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas","volume":"27","author":"Sanson","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib31","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.omton.2024.200840_bib32","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awm263","article-title":"Serum GFAP is a diagnostic marker for glioblastoma multiforme","volume":"130","author":"Jung","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.omton.2024.200840_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9440(10)65135-8","article-title":"Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter","volume":"155","author":"Fujisawa","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omton.2024.200840_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-022-01577-x","article-title":"Liquid biopsies to occult brain metastasis","volume":"21","author":"Rehman","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2024.200840_bib35","article-title":"Circulating Tumor Cells for Glioma","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib36","article-title":"The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma","volume":"15","author":"Halawa","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.omton.2024.200840_bib37","article-title":"Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response","volume":"16","author":"Buccilli","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.omton.2024.200840_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas","volume":"64","author":"Ohgaki","year":"2005","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omton.2024.200840_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep32067","article-title":"A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma","volume":"6","author":"Zhi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200840_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1515\/cclm-2017-0958","article-title":"Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors","volume":"56","author":"Kopkova","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.omton.2024.200840_bib42","article-title":"Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma","volume":"32","author":"Joshi","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib43","first-page":"4134","article-title":"Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes","volume":"10","author":"Aili","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ncrna.2024.02.011","article-title":"MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets","volume":"9","author":"Beylerli","year":"2024","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.omton.2024.200840_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ncrna.2022.07.001","article-title":"MicroRNAs as prognostic markers and therapeutic targets in gliomas","volume":"7","author":"Sufianov","year":"2022","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.omton.2024.200840_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejso.2009.07.010","article-title":"Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme","volume":"36","author":"Schuhmann","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-013-1201-8","article-title":"Altered galectin-1 serum levels in patients diagnosed with high-grade glioma","volume":"115","author":"Verschuere","year":"2013","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1215\/15228517-2008-114","article-title":"Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas","volume":"11","author":"Lin","year":"2009","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib49","first-page":"343","article-title":"Circulating glioma biomarkers","volume":"17","author":"Kros","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib50","doi-asserted-by":"crossref","first-page":"10904","DOI":"10.1039\/D3NR01667F","article-title":"Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy","volume":"15","author":"Wang","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.omton.2024.200840_bib51","first-page":"29","article-title":"The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring","volume":"36","author":"Hallal","year":"2019","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.omton.2024.200840_bib52","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/neuonc\/noy074","article-title":"Blood-based biomarkers for the diagnosis and monitoring of gliomas","volume":"20","author":"Zachariah","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneurol.2015.171","article-title":"Circulating biomarkers for gliomas","volume":"11","author":"Westphal","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omton.2024.200840_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40263-023-01016-5","article-title":"BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets","volume":"37","author":"Muniz","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.omton.2024.200840_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.wneu.2020.12.029","article-title":"Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis","volume":"147","author":"Kai","year":"2021","journal-title":"World Neurosurg."},{"key":"10.1016\/j.omton.2024.200840_bib56","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S50208","article-title":"Personalized treatment strategies in glioblastoma: MGMT promoter methylation status","volume":"6","author":"Thon","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.omton.2024.200840_bib57","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1078-0432.CCR-03-0384","article-title":"Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide","volume":"10","author":"Hegi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10014-021-00424-z","article-title":"Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas","volume":"39","author":"Arita","year":"2022","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.omton.2024.200840_bib59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/modpathol.2014.94","article-title":"TERT promoter mutations contribute to subset prognostication of lower-grade gliomas","volume":"28","author":"Chan","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.omton.2024.200840_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40478-020-01078-2","article-title":"TERT promoter mutation confers favorable prognosis regardless of 1p\/19q status in adult diffuse gliomas with IDH1\/2 mutations","volume":"8","author":"Arita","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omton.2024.200840_bib61","doi-asserted-by":"crossref","first-page":"24871","DOI":"10.18632\/oncotarget.4549","article-title":"TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200840_bib62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.omton.2024.200840_bib63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-015-0163-4","article-title":"Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis","volume":"34","author":"Wu","year":"2015","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1756-9966-27-85","article-title":"Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients","volume":"27","author":"Zhang","year":"2008","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib65","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2015.1.FOCUS14745","article-title":"Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas","volume":"38","author":"Chen","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.omton.2024.200840_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1470-2045(10)70053-X","article-title":"Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?","volume":"12","author":"Kloosterhof","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00125480-200307000-00004","article-title":"Genetic markers in glioblastoma: prognostic significance and future therapeutic implications","volume":"10","author":"Hill","year":"2003","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.omton.2024.200840_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/neuonc\/1.3.169","article-title":"A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution","volume":"1","author":"Wooten","year":"1999","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111115","article-title":"MicroRNAs involved in the EGFR pathway in glioblastoma","volume":"134","author":"Xu","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.omton.2024.200840_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020587","article-title":"Updated Insights on EGFR Signaling Pathways in Glioma","volume":"22","author":"Oprita","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200840_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11060-015-1978-8","article-title":"Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma","volume":"126","author":"Tichy","year":"2016","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib72","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.7314\/APJCP.2014.15.24.10893","article-title":"Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.omton.2024.200840_bib73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1148\/radiol.2016160024","article-title":"Release of Cell-free MicroRNA Tumor Biomarkers into the Blood Circulation with Pulsed Focused Ultrasound: A Noninvasive, Anatomically Localized, Molecular Liquid Biopsy","volume":"283","author":"Chevillet","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.omton.2024.200840_bib74","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1109\/TBME.2022.3221887","article-title":"Characterization of the Targeting Accuracy of a Neuronavigation-Guided Transcranial FUS System In\u00a0Vitro, In\u00a0Vivo, and In Silico","volume":"70","author":"Xu","year":"2023","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.omton.2024.200840_bib75","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230047","article-title":"Sonobiopsy for Neurodegenerative Diseases: At the Intersection of Diagnostic and Therapeutic US","volume":"307","author":"Fowlkes","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.omton.2024.200840_bib76","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3171\/jns.2005.102.5.0897","article-title":"Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases","volume":"102","author":"McGirt","year":"2005","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.omton.2024.200840_bib77","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1038\/s41598-018-24516-7","article-title":"Focused Ultrasound-enabled Brain Tumor Liquid Biopsy","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200840_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-021-03837-0","article-title":"Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients","volume":"156","author":"Rincon-Torroella","year":"2022","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib79","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2024.200840_bib80","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","article-title":"Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes","volume":"26","author":"Nassiri","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2024.200840_bib81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-019-0603-6","article-title":"Circulating biomarkers in patients with glioblastoma","volume":"122","author":"M\u00fcller Bark","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2024.200840_bib82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1078-0432.CCR-20-3083","article-title":"TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas","volume":"27","author":"Muralidharan","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","article-title":"Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study","volume":"26","author":"Bagley","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200840_bib84","doi-asserted-by":"crossref","first-page":"28","DOI":"10.37349\/etat.2023.00121","article-title":"Liquid biopsy and glioblastoma","volume":"4","author":"Eibl","year":"2023","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.omton.2024.200840_bib85","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","article-title":"Applications of focused ultrasound in the brain: from thermoablation to drug delivery","volume":"17","author":"Meng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omton.2024.200840_bib86","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1088\/0031-9155\/34\/11\/021","article-title":"High intensity focused ultrasound--a surgical technique for the treatment of discrete liver tumours","volume":"34","author":"ter Haar","year":"1989","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.omton.2024.200840_bib87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40846-018-0391-0","article-title":"Ultrasound Cavitation\/Microbubble Detection and Medical Applications","volume":"39","author":"Izadifar","year":"2019","journal-title":"J.\u00a0Med. Biol. Eng."},{"key":"10.1016\/j.omton.2024.200840_bib88","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1073\/pnas.2002571117","article-title":"Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound","volume":"117","author":"Rezai","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2024.200840_bib89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3174\/ajnr.A3150","article-title":"Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swine","volume":"34","author":"Wei","year":"2013","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.omton.2024.200840_bib90","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1038\/s41598-018-25904-9","article-title":"Efficient Blood-Brain Barrier Opening in Primates with Neuronavigation-Guided Ultrasound and Real-Time Acoustic Mapping","volume":"8","author":"Wu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200840_bib91","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2014.9.FOCUS14521","article-title":"Molecular and cellular heterogeneity: the hallmark of glioblastoma","volume":"37","author":"Aum","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.omton.2024.200840_bib92","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220869","article-title":"Focused Ultrasound-mediated Liquid Biopsy in a Tauopathy Mouse Model","volume":"307","author":"Pacia","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.omton.2024.200840_bib93","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/s41598-020-64440-3","article-title":"Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine model","volume":"10","author":"Pacia","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200840_bib94","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41698-023-00448-y","article-title":"First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound","volume":"7","author":"Yuan","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.omton.2024.200840_bib95","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2008-1053478","article-title":"Frameless neuronavigation in modern neurosurgery","volume":"38","author":"Spetzger","year":"1995","journal-title":"Minim. Invasive Neurosurg."},{"key":"10.1016\/j.omton.2024.200840_bib96","first-page":"1123","article-title":"Neuronavigation and surgery of intracerebral tumours","volume":"253","author":"Willems","year":"2006","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.omton.2024.200840_bib97","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2009.6.FOCUS09109","article-title":"Neuronavigation: geneology, reality, and prospects","volume":"27","author":"Enchev","year":"2009","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.omton.2024.200840_bib98","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41467-021-21022-9","article-title":"Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia","volume":"12","author":"Gasca-Salas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200840_bib99","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1038\/s41467-019-12426-9","article-title":"First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound","volume":"10","author":"Abrahao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200840_bib100","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1109\/TUFFC.2013.6644731","article-title":"Dependence of the reversibility of focused- ultrasound-induced blood-brain barrier opening on pressure and pulse length in\u00a0vivo","volume":"60","author":"Samiotaki","year":"2013","journal-title":"IEEE Trans. Ultrason. Ferroelectrics Freq. Control"},{"key":"10.1016\/j.omton.2024.200840_bib101","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/jcbfm.2012.100","article-title":"Dynamic Study of Blood\u2013Brain Barrier Closure after its Disruption using Ultrasound: A Quantitative Analysis","volume":"32","author":"Marty","year":"2012","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.omton.2024.200840_bib102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2012.06.012","article-title":"The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound","volume":"162","author":"Park","year":"2012","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omton.2024.200840_bib103","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jconrel.2020.05.040","article-title":"Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood-brain barrier","volume":"324","author":"Todd","year":"2020","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omton.2024.200840_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94188-3","article-title":"Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primates","volume":"11","author":"Pouliopoulos","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200840_bib105","article-title":"Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors","volume":"7","author":"Chen","year":"2021","journal-title":"Sci. Adv."}],"container-title":["Molecular Therapy: Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:20:09Z","timestamp":1726838409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329924000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2950329924000821"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2024.200840","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of sonobiopsy as a novel diagnosis tool for brain cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy: Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2024.200840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200840"}}